Strategy of Pharmacological Regulation of Intracellular Signal Transduction in Regeneration-Competent Cells

Bulletin of Experimental Biology and Medicine
G N Zyuz'kovV V Udut

Abstract

The study focuses on the development of principally novel priority-oriented healthcare strategy - targeted therapy in regenerative medicine known as Strategy of Pharmacological Control over Intracellular Signal Transduction in Regeneration-Competent Cells. It implies selective action of promising drugs on specific key elements in the signaling cascade responsible for functional activity of various progenitor cells (including stem cells) and elements of tissue microenvironment. The results of pioneer studies are described that were aimed on revealing the peculiarities in signal transduction and the role of distinct signaling molecules (the potential targets) in the control of cell cycle and other functions of progenitor elements and regulatory cells of different types. The models of some pathological states were employed to demonstrate the possibility of effective implementation of the advanced pharmacotherapeutic concept. The developed theoretical and applied platform can be used to launch synthesis of principally novel preparations with regenerative activity.

References

May 23, 1998·Annual Review of Immunology·W J Leonard, J J O'Shea
Jun 9, 2001·Experimental Biology and Medicine·J J MinguellP Conget
Dec 10, 2002·Science·G ManningS Sudarsanam
Jan 1, 2008·International Journal of Chronic Obstructive Pulmonary Disease·David M G Halpin
May 5, 2009·American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics·Sebastian Baumgaertel
Dec 18, 2010·Bulletin of Experimental Biology and Medicine·A M DygaiP G Madonov
Mar 11, 2011·Nature Reviews. Cancer·Uri Ben-David, Nissim Benvenisty
Jul 14, 2011·Regenerative Medicine·Ruenn Chai LaiSai Kiang Lim
Jul 14, 2011·Regenerative Medicine·Juan-Carlos Biancotti, Nissim Benvenisty
Dec 14, 2011·Journal of Cellular and Molecular Medicine·Sabine SchuThomas Ritter
May 9, 2014·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Simonetta M Leto, Livio Trusolino
Jun 3, 2015·Bulletin of Experimental Biology and Medicine·G N Zyuz'kovA M Dygai
Mar 30, 2017·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Célia FaustinoCatarina Pinto Reis
Jun 6, 2017·Bulletin of Experimental Biology and Medicine·G N Zyuz'kovV V Zhdanov
Oct 5, 2017·International Journal of Molecular Sciences·Silvia BaldariGabriele Toietta

❮ Previous
Next ❯

Citations

Feb 10, 2021·Journal of Basic and Clinical Physiology and Pharmacology·Gleb Nikolaevich Zyuz'kovTatyana Yur Evna Polykova
Jul 24, 2021·Bulletin of Experimental Biology and Medicine·G N Zyuz'kovA V Chaikovskii

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.